Nifekalant hydrochloride for patients with cardiac arrest caused by shockable rhythm.
Ken
K
Nagao
D000889:Anti-Arrhythmia Agents / Q000008:administration & dosage*; D047548:Defibrillators; D004554:Electric Countershock / Q000295:instrumentation; D006801:Humans; D058687:Out-of-Hospital Cardiac Arrest / Q000188:drug therapy / Q000209:etiology / Q000401:mortality / Q000628:therapy*; D010343:Patient Admission; D011744:Pyrimidinones / Q000008:administration & dosage*; D015996:Survival Rate; D017180:Tachycardia, Ventricular / Q000150:complications / Q000188:drug therapy / Q000401:mortality / Q000628:therapy*; D013997:Time Factors; D016171:Torsades de Pointes / Q000139:chemically induced; D017211:Treatment Failure; D014693:Ventricular Fibrillation / Q000150:complications / Q000188:drug therapy / Q000401:mortality / Q000628:therapy*
D000889:Anti-Arrhythmia Agents; D011744:Pyrimidinones; C076259:nifekalant